News

Watch Video BOSTON — Dana-Farber Cancer Institute has launched a new clinical trial aimed at detecting cancer earlier among U.S. veterans. The study, called the Sentinel Study, plans to enroll 1,500 veterans and is supported in part by a grant from the Department of Defense. By leveraging multi-cancer early detection (MCED) blood tests, the trial aims to identify cancer signals long before symptoms appear, offering veterans a potentially life-saving advantage. Veterans face

Link to Article: https://blog.dana-farber.org/insight/2025/02/early-cancer-detection-studies-for-high-risk-people/ The Sentinel study , led by O’Donnell and Marinac and funded by the U.S. Department of Defense, is working with military veterans, including those:  Over age 45.  Who were on active-duty military service for eight or more years.  Received care at a Veterans Administration facility within the past five years.  “There’s accumulating evidence suggesting that veteran

On October 16th, the Multi-Cancer Early Detection (MCED) team successfully participated in the Malden Community Health Fair. Our team connected with local service members, presenting information about the SENTINEL Study and enrolling interested veterans directly on-site to help advance critical cancer detection research.

On October 16th, the Multi-Cancer Early Detection (MCED) team participated as a Massachusetts health resource at the MA Veteran Job Fair in Brighton. The team engaged with local veterans to provide information about the SENTINEL Study and offered on-site enrollment opportunities, emphasizing the importance of early cancer detection research for those who have served.

The GRAIL Boston MCED Summit was held on Thursday, October 2, 2025, in Boston, MA. The Sentinel Study team engaged with providers, primary care doctors, and listened to patient stories to learn more about Multi-Cancer Early Detection (MCED) technology developed by GRAIL. This participation ensures the team remains connected to the clinical community and the latest advancements in early cancer screening.

On September 19th, the Sentinel Study Team successfully connected with the local veteran community at the Monmouth County Health Fair in Lincroft, New Jersey. The team was able to engage with attendees, resulting in the enrollment of new participants and the collection of essential blood samples to advance the study's research goals.

On September 6th, we were honored to meet vets in person at the HunterSeven Foundation's First Annual “F*CK CANCER” Motorcycle Run at the Whitman VFW post in Whitman, MA. Our team joined post-9/11 veterans to support those riding to raise cancer awareness among veterans and connected with new participants for the SENTINEL study. The onsite team helped make enrollment quick and simple for interested veterans, collecting surveys and completing the GRAIL Galleri blood test that

The Sentinel Study team participated in the NJ Health Fair at the Veterans Foundation of America in Bordentown, NJ, on August 26th. Our team presented comprehensive information about the SENTINEL study, successfully engaged with dozens of veterans, and enrolled several new participants on-site.

The American Legion National Convention held on August 22-25th in Tampa, FL is an annual event hosted by the nation’s leading veterans service organization and draws around 9,000 members. Our team connected with veterans, enrolling some on-site to the SENTINEL study and others who reached out after the event. We also built valuable relationships with delegates from American Legion posts across the country who will help spread the word about our study.